David Allsop - Publications & Outputs - Research Portal

Professor David Allsop

Formerly at Lancaster University

1 - 10 out of 154Page size: 10

RSS feed of this list

Sort by: Title

Published
3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of β-amyloid peptide.
Allsop, D., Gibson, G., Martin, I. K., Moore, S., Turnbull, S. & Twyman, L. J., 01/2001, In: Bioorganic and Medicinal Chemistry Letters. 11, 2, p. 255-257 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits
Gentleman, S. M., Bruton, C., Allsop, D., Lewis, S. J., Polak, J. M. & Roberts, G. W., 1989, In: Histochemistry. 92, 4, p. 355-358 4 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson’s disease
Foulds, P., Diggle, P., Mitchell, J. D., Parker, A., Hasegawa, M., Masuda-Suzukake, M., Mann, D. M. A. & Allsop, D., 29/08/2013, In: Scientific Reports. 3, 6 p., 2540.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A monoclonal antibody to common acute lymphoblastic leukemia antigen (neutral endopeptidase) immunostains senile plaques in the brains of patients with Alzheimer's disease
Sato, M., Ikeda, K., Haga, S., Allsop, D. & Ishii, T., 2/01/1991, In: Neuroscience Letters. 121, 1-2, p. 271-273 3 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation
Allsop, D., Taylor, M. N., Fullwood, N. J., Michael, M., Aggidis, A., Vincent, S. & Dale, M., 1/11/2017, In: Journal of Prevention of Alzheimer's Disease. 4, 4, p. 385-386 2 p.
Research output: Contribution to Journal/Magazine › Meeting abstract › peer-review
Published
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's Disease
Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M. & Allsop, D., 2013, In: PLoS ONE. 8, 1, 11 p., e54769.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A possible key role for redox-active metal ions and soluble oligomers in neurodegenerative diseases
Tabner, B., Moore, S., Mayes, J. & Allsop, D., 2013, Brain diseases and metalloproteins. Brown, D. R. (ed.). Boca Raton, Fla.: Pan Stanford, p. 11-32 22 p.
Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSN › Chapter
Published
A possible unified nomenclature for Alzheimer amyloid protein, precursors and gene
Allsop, D., 01/1990, In: Neurobiology of Aging. 11, 1, p. 69 1 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A preliminary electron microscopic investigation into the interaction between Aβ1-42 peptide and a novel nanoliposome- coupled retro-inverso peptide inhibitor, developed as a potential treatment for Alzheimer's disease
Sherer, M., Fullwood, N. J., Taylor, M. & Allsop, D., 1/10/2015, In: Journal of Physics: Conference Series. 644, 1, 4 p., 012040.
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Published
A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran.
Twyman, L. J. & Allsop, D., 12/1999, In: Tetrahedron Letters. 40, 52, p. 9383-9384 2 p.
Research output: Contribution to Journal/Magazine › Journal article › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

Research

Professor David Allsop

3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of β-amyloid peptide.

A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson’s disease

A monoclonal antibody to common acute lymphoblastic leukemia antigen (neutral endopeptidase) immunostains senile plaques in the brains of patients with Alzheimer's disease

A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation

A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's Disease

A possible key role for redox-active metal ions and soluble oligomers in neurodegenerative diseases

A possible unified nomenclature for Alzheimer amyloid protein, precursors and gene

A preliminary electron microscopic investigation into the interaction between Aβ1-42 peptide and a novel nanoliposome- coupled retro-inverso peptide inhibitor, developed as a potential treatment for Alzheimer's disease

A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran.

Quick Links

Connect With Us

Faculties & Depts

Contact Us